Exhibit 10.2


 





First Amendment
to Consulting Agreement


 


This First Amendment (“Amendment”)
to the consulting Agreements signed on June 18, 2013, and is effective as of March 30, 2014 (the “Amendment Date”),
and is entered into by and among:


 


		(i)	Dalian Wanchun Pharmaceutical Co., Ltd., a China corporation, having a principal place
of business at No. 9 Liaohe East Road, Dalian Economic Development Zone, Dalian, China 116025 (“Dalian”);



 


		(ii)	GKOL, Inc., a California corporation, with an office at 13932 Dodder
Court, Poway, CA 92064 (“GKOL”); and



 


		(iii)	BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with
an office at 48 Wall Street, 11th Floor, New York, New York 10005 USA (“BeyondSpring”).



 


WITNESSETH:


 


WHEREAS,
GKOL and Dalian are parties to the Consulting Agreement, with an effective date of June 18, 2013 (the “Agreement”);


 


WHEREAS,
the Agreement sets forth certain rights and obligations of the parties relating to the provision of certain Services (as defined
in the Agreement) by GKOL to Dalian; and


 


WHEREAS,
BeyondSpring, a US corporate affiliate of Dalian, took over the rights and responsibility of Dalian on Plinabulin (NPI-2358) and
the Agreement. BeyondSpring wishes to engage GKOL to perform certain Services under the Agreement for BeyondSpring. Dalian signed
the Agreement and made payments on behalf of BeyondSpring;


 


WHEREAS,
the parties hereto desire to amend the Agreement to add BeyondSpring as the client, and remove Dalian as the client, as more fully
described below;


 


NOW
THEREFORE, in consideration of the covenants contained herein the parties hereto, intending to be legally bound hereby, agree as
follows:


 


		1.	BeyondSpring Pharmaceuticals, Inc. is hereby added as the sole client party
to the Consulting Agreement.



 


		2.	All instances of the words “Dalian Wanchun Pharmaceutical Co. Ltd”
in the Agreement are hereby deleted and replaced with the word “BeyondSpring Pharmaceuticals, Inc.”.



 


		3.	Except to the extent expressly amended hereby, all other terms and conditions
of the Agreement are hereby ratified and the parties agree and acknowledge that they are subject to the Agreement and the same
is in full force and effect.



 


		4.	This Amendment and the Agreement, constitute
the entire agreement between the parties with respect to the subject matter contained therein, and together, supersede and replace
any and all prior and contemporaneous understandings, arrangements and agreements, whether oral or written, with respect
to the subject matter.



 


		5.	This Amendment shall be construed and interpreted in accordance with the laws of the State of
Maryland without giving effect to its principles of conflicts of laws.



 






    	 



    	 



    

 


IN WITNESS WHEREOF, the parties
have caused this Amendment to be executed by their duly authorized representatives, to be effective as of the Amendment Date regardless
of the date actually signed.


 


	GKOL, Inc.,	 	Dalian Wanchun Pharmaceutical Co., Ltd.
	 	 	 
	 	 	 	 	 
	By: 	/s/ G. Kenneth Lloyd	 	By:	/s/ Lan Huang
	Name: Ken Lloyd, Ph.D.	 	Name: Lan Huang, Ph.D.
	Title: Vice President 	 	Title: CEO
	Date: March 30, 2014	 	Date: March 30, 2014
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	BeyondSpring Pharmaceuticals, Inc.
	 	 	 	 
	 	 	 	 
	 	 	 	By:	/s/ Lan Huang
	 	 	 	Name: Lan Huang, Ph.D.
	 	 	 	Title: CEO
	 	 	 	Date: March 30, 2014